One in Five Women Has Re-Op After Breast Cancer Surgery

Share this article:
One in Five Women Has Re-Op After Breast Cancer Surgery
One in Five Women Has Re-Op After Breast Cancer Surgery

(HealthDay News) – Twenty percent of women who undergo breast conserving surgery in England undergo reoperation, which is significantly more likely for women with carcinoma in situ vs. isolated invasive disease.

Ranjeet Jeevan, from the Royal College of Surgeons in London, and colleagues examined whether the rates of reoperation correlated with patient characteristics in a cohort of 55,297 women who underwent primary breast conserving surgery in 156 National Health Service (NHS) Trusts from April 2005–March 2008.

The researchers found that 20% of the women had at least one reoperation, and 18.5% had only one reoperation. Of those who had only one reoperation, 10.7 and 7.7% had another breast conserving procedure and a mastectomy, respectively. Eighteen percent of the 45,793 women with isolated invasive disease had at least one reoperation, compared with 29.5% of the 9,504 women with carcinoma in situ (adjusted odds ratio, 1.9). There were considerable differences in the adjusted reoperation rates between different NHS trusts.

"Cosmetic outcomes after surgery for breast cancer are an important consideration, and women should be made aware of the local rates of reoperation after primary breast conserving surgery, along with the likelihood of proceeding to mastectomy," the authors write.

Full Text

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs